United States Hospital-acquired Infections Prevention Market Report, 2010-2020

1. India Adhesives Market Forecast & Opportunities, 2020 Prevention Market Opportunities, 2010-2020 United States Hospital-acquired Infections P h a r m a & H e a l t h c a r e C o n s u l t a n t s

2. Re s e a rc h M e t h o d o l o g y US Hospital-acquired Infections Prevention Market Opportunities, 2020 Secondary Research Primary Research •Government websites •Company annual reports, white papers, investor presentations and financial reports •Identifying Key Opinion Leaders •Questionnaire Design •In-depth Interviews •Coverage across Value Chain market Preliminary Data Mining Qualitative and Quantitative research Data Validation, Analysis and Interpretation Data validation through Primary & Secondary outreach, data analysis and interpretation of key findings Market Estimation & Forecasting Bottom-Up or Top-down approach for Market size estimation Historical trend examination Impact analysis of drivers and challenges to market growth Statistical evaluation to develop the actual forecast CAGR (2015E-2020F): XX% 2 © Pharmaion 2015E 2016F 2017F 2018F 2019F 2020F

3. Re s e a rc h M e t h o d o l o g y Baseline Methodology: For the study of the United States hospital-acquired infections prevention market, Pharmaion has gathered information through an exhaustive search of credible databases prudently evaluated all the collected information and presented it in the most accurate and detailed manner. Primary Sources Qualitative and quantitative data from company website, financial reports, research articles, designed questionnaires etc. Key Stakeholders:  Product/Brand Managers  Business Development Managers  Regional Mangers  Regulatory Affairs Personnel  Marketing & Sales Managers  Head of Patient Support Programme In-depth interviews of key stakeholders of major companies Data Triangulation (Data validation through cross verification from primary & secondary sources) Secondary Sources Analysis of Data from credible sources:  Centers for Disease Control and Prevention (CDC)  American Cancer Institute  American Hospital Directory Substantial data points for analysis, interpretation and market size estimation 3 © Pharmaion

4. Re s e a rc h M e t h o d o l o g y United States Hospital-acquired Infections Prevention Market - Market Size Estimation  United States Hospital-acquired Infections Prevention market has been segmented into two categories: Disinfection and Sterilization  Sterilization has been further categorized into Consumables  Disinfection has been further classified into six sub segments: Disinfection Robots, Disinfectants, Endoscope Reprocessors, Disinfectors, Wipes, and Personal-use Non-wovens. three sub-segments: Equipment, Services, and Total Market Size = Sterilization Market Size + Disinfection Market Size Calculation of United States Sterilization for Hospital-acquired Infections Prevention Market Size Calculation of United States Disinfection for Hospital- acquired Infections Prevention Market Size Top-down Approach Bottom-up Approach Calculation of Sub- segment market size Regional & Company Market Size = Respective Market Share (from primary and secondary research) X Total Market Value Calculation of Sub- segment market size 4 © Pharmaion

5. Ta b l e o f C o n te n t s S No. Contents 1. Hospital-acquired Infections Prevention Overview 2. Research Methodology 3. Analyst View 4. Global Hospital-acquired Infections Prevention Market Overview 5. United States Hospital-acquired Infections Prevention Market Outlook 5.1. Market Size and Forecast 5.1.1. By Value 5.2. Market Share & Forecast 5.2.1. By Prevention Type 5.2.2. By Region 5.2.3. By Company 6. United States Sterilization for Hospital-acquired Infections Prevention Market Outlook 6.1. Market Size and Forecast 6.1.1. By Value 6.2. Market Share & Forecast 6.2.1. By Type 7. United States Disinfection for Hospital-acquired Infections Prevention Market Outlook 7.1. Market Size and Forecast 7.1.1. By Value 7.2. Market Share & Forecast 7.2.1. By Type 5 © Pharmaion

6. Ta b l e o f C o n te n t s S No. Contents 8. Market Dynamics 8.1. Drivers 8.2. Challenges 9. Market Trends & Developments 9.1. UV Disinfecting Robots – Future of Disinfection 9.2. Plummeting Surgical Site Infections 9.3. RFID – Technology for Monitoring Hand Hygiene 9.4. Gas Plasma Sterilization Technology 9.5. Hospital Infection Prevention from Digital Technology 10. Regulatory Framework and Guidelines 10.1. Deficit Reduction Act of 2005 10.2. Guidelines 11. United States Economic Profile 12. Competitive Landscape 12.1. Competition Benchmarking 12.2. Company Profiles 12.2.1. Steris Corporation 12.2.2. Advanced Sterilization Products 12.2.3. Getinge USA, Inc. 12.2.4. 3M Company 12.2.5. Belimed 6 12.2.6. Cantel Medical Corp. © Pharmaion

7. Ta b l e o f C o n te n t s S No. Contents 12.2.7. Halyard Health, Inc. 12.2.8. Cisa America Inc. 12.2.9. Cardinal Health, Inc. 12.2.10. Tuttnauer USA Co. Ltd. 13. Strategic Recommendations 14. About Us & Disclaimer 7 © Pharmaion

8. I n d u s t r y B r i e f United States Hospital-acquired Infections Prevention Market to Grow at Over 7% Until 2020 Growing incidence of hospital-acquired infections and stringent government policies to drive the United States hospital-acquired infections prevention market through 2020 According to recently published Pharmaion report,“United States Hospital-acquired Infections Prevention Market Opportunities, 2010 - 2020”, hospital-acquired infections prevention market in the United States is projected to grow at a CAGR of over 7% during 2015 - 2020. Growth in the US hospital-acquired infections prevention market can be attributed to growing incidence of hospital-acquired infections and rising prevalence of chronic diseases among geriatric population. Moreover, implementation of stringent laws against hospitals with regards to hospital- acquired infections, under the Deficit Regulation Act, 2005,is also anticipated to drive demand for hospital- acquired infections prevention market in the United States during 2015 - 2020. On the basis of prevention type, the market has been segmented into two categories, namely, sterilization and disinfection. Among these categories, sterilization segment dominated the United States hospital-acquired infections prevention market in 2014, and is anticipated to continue its dominance during forecast period on account of its high efficiency and capability to clean and kill microorganisms in extreme corners of medical devices used in diagnostic and treatment procedures. South region accounted for the largest share in the United States hospital-acquired infections prevention market in 2014, followed by the Midwest, West and North-East regions. “With increasing adoption of UV disinfecting robots and RFID, a technology for monitoring hand hygiene, coupled with growing adoption of gas plasma sterilization technology, the market for hospital-acquired infections prevention market in the United States is anticipated to grow at a robust pace over the next five years. Moreover, Office of Disease Prevention and Health Promotion (ODPHP) and US Department of Health and Human Services (HHS) developed the “National Action Plan to Prevent Health Care-Associated Infections: Road Map to Elimination” in 2009. This plan was focused to prevent hospital-acquired infections across all health care settings, including acute care hospitals, ambulatory surgical centres, end-stage renal disease facilities and long-term care facilities.” said Mr. Karan Chechi, Research Director, with Pharmaion Consultants, a research based global pharmaceutical and healthcare consulting firm. 8 © Pharmaion

9. H o s p i t a l - a c q u i re d I n f e c t i o n s P reve n t i o n O ve r v i e w Hospital-acquired Infections Hospital-acquired infection, also known as nosocomial infection, is defined as an infection whose development takes place in a favourable hospital environment, specifically those which are acquired by a patient during a hospital visit and often develop among the hospital staff. Hospital-acquired infections majorly leads to severe pneumonia and infections of bloodstream, urinary tract and other parts of the body. United States Hospital-acquired Infections Share, 2013 Abbreviations Used: XXXX VAP, 20% SSI, 20% XXXX XXXX CLABSI, 20% XXXX CAUTI, 20% XXXX HO-HCFA CDI, 20% 9 © Pharmaion

10. S a m p l e D a t a - S n a p s h o t North-East Region United States Hospital-acquired Infections Prevention Market Size, By Region, By Value, 2010-2014 (USD Million) 5 Midwest Region 4 5 3 2 4 1 3 2 1 2010 2011 2012 2013 2014 2010 2011 2012 2013 2014 United States Costs of Commonly Hospital-acquired West Region Infections Diagnosis & Treatment, 2012 (%) 5 4 Catheter- associated UTIs, 20.0% 3 Surgical Site Infections, 20.0% 2 South Region 1 5 4 3 2 2010 2011 2012 2013 2014 C. Difficile Infections, 20.0% 1 Ventilator- associated Pneumonia, 20.0% Central line- associated bloodstream infection, 20.0% 2010 2011 2012 2013 2014 United States Number of Deaths from 10 Leading Causes, 2013 10 9 8 United States Hospital-acquired Infections Prevention Market Share, By 7 6 5 4 3 Company, By Value, 2010-2020F 2 1 31% 31.1% 31.2% 31.3% 31.4% 31.5% 31.6% 31.7% 31.8% 31.9% 32% 16% 16.1% 16.2% 16.3% 16.4% 16.5% 16.6% 16.7% 16.8% 16.9% 17% 14% 14.1% 14.2% 14.3% 14.4% 14.5% 14.6% 14.7% 14.8% 14.9% 15% United States Hospital-acquired Infections Prevention 5% 5.1% 5.2% 5.3% 5.4% 5.5% 5.6% 5.9% 5.7% 5.8% 6% Market Size, By Value, 2010-2020F (USD Billion) 11 10 30.1% 30.2% 30.3% 30.4% 30.5% 30.6% 30.7% 30.8% 30.9% 31% 9 31.1% 8 7 6 5 4 3 2 1 2010 2011 2012 2013 2014 2015E 2016F 2017F 2018F 2019F 2020F 10 Others 3M Company Getinge USA Inc. ASP Steris Corporation © Pharmaion

11. Re p o r t O rd e r i n g Report Name: United States Hospital-acquired Infections Prevention Market Opportunities, 2010-2020 Report Price License Type Price Single User License $2500 Single User License Print $3000 Enterprise License $5000 To View Sample OR Purchase Report 11 © Pharmaion

12. A b o u t U s & D i s c l a i m e r About Us : Pharmaion is a research based management consulting firm focused exclusively on Healthcare & Pharmaceutical industry. Pharmaion’s core values are value, integrity and insight. Led by a team of dynamic industry experts, Pharmaion provides its customers with high value market research and advisory services that helps them identify new market opportunities, growth engines and innovative ways to capture the market share. As a result, Pharmaion’s clients lead rather than follow market trends. Not bound by legacy, Pharmaion’s cutting-edge research model leverages its decades of research knowledge and an increased use of technology as engines of innovation to deliver unique research value. Provided as an alternative to traditional market research, Pharmaion’s reports do not just deliver data and knowledge rather highlights the insights in a more usable and interactive format for its clients. Pharmaion is committed to assisting customers worldwide with their unique market research needs by providing them with comprehensive, value-added solutions and professional market intelligence services. Pharmaion employs the industry’s best-trained industry Analysts and Consultants, which advises and assists customers in meeting their full service market research and consulting requirements. Related Reports United States Autoimmune Disorders Diagnostics Market Opportunities, 2020 Global Tissue Engineered Medical Devices Market Opportunities, 2020 Global Cervical Cancer Vaccine Market Opportunities, 2020 Disclaimer : The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely, accurate or complete. Pharmaion Consultants has taken due care and caution in compilation of data as this has been obtained from various sources including which it considers reliable and first hand. However, Pharmaion Consultants does not guarantee the accuracy, adequacy or completeness of any information and it is not responsible for any errors or omissions or for the results obtained from the use of such information and especially states that it has no financial liability whatsoever to the subscribers / users of this report. The information herein, together with all estimates and forecasts, can change without notice. All the figures provided in this document are indicative of relative market size and are strictly for client’s internal consumption. Usage of the same for purpose other than internal will require prior approval of Pharmaion Consultants. NORTH AMERICA Pharmaion Consultants LLC 708 3RD Avenue, 6th Floor, New York, NY, United State, 10017 sales@pharmaion.com +1 646 360 1656 www.pharmaion.com ASIA PACIFIC Pharmaion Consultants Pvt. Ltd. A – 51, Sector 57, Noida, National Capital Region, India - 201301 sales@pharmaion.com +91 - 120 - 452 3900 www.pharmaion.com 12 © Pharmaion